| Q38956287 | A HAART-Breaking Review of Alternative Antiretroviral Administration: Practical Considerations with Crushing and Enteral Tube Scenarios |
| Q88388194 | A Refined Developability Classification System |
| Q37803213 | A biorelevant dissolution stress test device - background and experiences. |
| Q48047695 | A framework for multi-scale simulation of crystal growth in the presence of polymers. |
| Q52065823 | A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling. |
| Q43893051 | A nanosystem for water-insoluble drugs prepared by a new technology, nanoparticulation using a solid lipid and supercritical fluid |
| Q34730346 | A novel domperidone hydrogel: preparation, characterization, pharmacokinetic, and pharmacodynamic properties |
| Q45836862 | A novel three-dimensional large-pore mesoporous carbon matrix as a potential nanovehicle for the fast release of the poorly water-soluble drug, celecoxib |
| Q40663729 | A structure-permeability study of small drug-like molecules. |
| Q33878344 | Absorption Study of Genistein Using Solid Lipid Microparticles and Nanoparticles: Control of Oral Bioavailability by Particle Sizes |
| Q38149155 | Advances in dissolution instrumentation and their practical applications |
| Q37889295 | Advances in gastro retentive drug-delivery systems |
| Q42012662 | Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer |
| Q38651980 | An overview of prodrug technology and its application for developing abuse-deterrent opioids |
| Q64249555 | Applying Supercritical Fluid Technology to Prepare Ibuprofen Solid Dispersions with Improved Oral Bioavailability |
| Q38869855 | Assessing cooperativity in supramolecular systems. |
| Q50575414 | Assessment of Age-Related Changes in Pediatric Gastrointestinal Solubility. |
| Q48273811 | Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks. |
| Q35965791 | Biowaivers for oral immediate-release products: implications of linear pharmacokinetics |
| Q87209269 | Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method |
| Q87724885 | Characterization and evaluation of multi-component crystals of hydrochlorothiazide |
| Q45201753 | Characterization of preclinical in vitro and in vivo ADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA-14, a new dopamine D3 receptor antagonist candidate for treatment of drug addiction |
| Q41987217 | Characterization of the distribution, polymorphism, and stability of nimodipine in its solid dispersions in polyethylene glycol by micro-Raman spectroscopy and powder X-ray diffraction |
| Q39478705 | Chitosan and chitosan chlorhydrate based various approaches for enhancement of dissolution rate of carvedilol. |
| Q58802577 | Cholinium-based ionic liquids with pharmaceutically active anions |
| Q89910002 | Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability |
| Q64987944 | Cocrystals Mitigate Negative Effects of High pH on Solubility and Dissolution of a Basic Drug. |
| Q44787648 | Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: effect of bile in the incubation medium |
| Q79680806 | Comparative evaluation of ibuprofen/beta-cyclodextrin complexes obtained by supercritical carbon dioxide and other conventional methods |
| Q36307613 | Controlled Drug Delivery: Historical perspective for the next generation |
| Q49145146 | Correlation between the systemic clearance of drugs and their food effects in humans |
| Q38021953 | Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds |
| Q57134491 | DSC, FTIR and Raman Spectroscopy Coupled with Multivariate Analysis in a Study of Co-Crystals of Pharmaceutical Interest |
| Q47761828 | Decreased Absorption of Dolutegravir and Tenofovir Disoproxil Fumarate, But Not Emtricitabine, in an HIV-Infected Patient Following Oral and Jejunostomy-Tube Administration. |
| Q42000499 | Design and evaluation of self-nanoemulsifying drug delivery system of flutamide |
| Q36112240 | Development and Evaluation of Novel Self-Nanoemulsifying Drug Delivery Systems Based on a Homolipid from Capra hircus and Its Admixtures with Melon Oil for the Delivery of Indomethacin |
| Q41989615 | Development and characterization of zaleplon solid dispersion systems: a technical note |
| Q91704415 | Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets |
| Q37361015 | Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters |
| Q37021478 | Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug |
| Q83524910 | Development of solid self-emulsifying drug delivery system (SEDDS) I: use of poloxamer 188 as both solidifying and emulsifying agent for lipids |
| Q41195506 | Development, characterisation and evaluation of supersaturated triglyceride free drug delivery (s-TFDDS) of lornoxicam |
| Q40626528 | Differential and Special Properties of the Major Human UGT1-encoded Gastrointestinal UDP-glucuronosyltransferases Enhance Potential to Control Chemical Uptake |
| Q44528889 | Differential scanning calorimetry differences in micronized and unmicronized nimesulide uptake processes in biomembrane models. |
| Q39424063 | Dissolution and solid-state characterization of poorly water-soluble drugs in the presence of a hydrophilic carrier |
| Q38548980 | Dissolution behavior of β-cyclodextrin molecular inclusion complexes of aceclofenac |
| Q40976824 | Dissolution studies of physical mixtures of indomethacin with alpha- and gamma-cyclodextrins |
| Q37109079 | Drug nanoparticles: formulating poorly water-soluble compounds |
| Q38470559 | Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations |
| Q45834775 | Dynamic dissolution testing to establish in vitro/in vivo correlations for montelukast sodium, a poorly soluble drug |
| Q90692874 | Effect of Food and an Animal's Sex on P-Glycoprotein Expression and Luminal Fluids in the Gastrointestinal Tract of Wistar Rats |
| Q43002669 | Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats. |
| Q38534116 | Effect of drug physico-chemical properties on the efficiency of top-down process and characterization of nanosuspension |
| Q44786246 | Effect of hydrodynamic environment on tablets dissolution rate |
| Q34799545 | Effect of ingested lipids on drug dissolution and release with concurrent digestion: a modeling approach |
| Q41987237 | Effect of physical state and particle size distribution on dissolution enhancement of nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation |
| Q28821517 | Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique |
| Q39423753 | Enhancing and sustaining AMG 009 dissolution from a bilayer oral solid dosage form via microenvironmental pH modulation and supersaturation |
| Q39423453 | Enhancing and sustaining AMG 009 dissolution from a matrix tablet via microenvironmental pH modulation and supersaturation |
| Q42583413 | Evaluation of nanosuspensions for absorption enhancement of poorly soluble drugs: in vitro transport studies across intestinal epithelial monolayers |
| Q45078978 | Evaluation of performance of co crystals of mefloquine hydrochloride in tablet dosage form. |
| Q46534447 | Exploration of intestinal calcium precipitation as a barrier to absorption at high calcium doses |
| Q42926578 | Factors Affecting Calcium Precipitation During Neutralisation in a Simulated Intestinal Environment |
| Q48237580 | Floating solid cellulose nanofibre nanofoams for sustained release of the poorly soluble model drug furosemide |
| Q38676387 | Forensic entomotoxicology revisited-towards professional standardisation of study designs. |
| Q41497081 | Formulation and Characterization of Solid Dispersion Prepared by Hot Melt Mixing: A Fast Screening Approach for Polymer Selection |
| Q85560544 | Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan |
| Q42433654 | Hot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperine |
| Q91555565 | Impact of Acid-Reducing Agents on Gastrointestinal Physiology and Design of Biorelevant Dissolution Tests to Reflect These Changes |
| Q36909306 | Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans |
| Q91695839 | Impact of water hardness on oxytetracycline oral bioavailability in fed and fasted piglets |
| Q42954100 | Improved Pharmacokinetics of AMG 517 Through Co-Crystallization Part 1: Comparison of Two Acids With Corresponding Amide Co-crystals |
| Q36909324 | In vitro models for processes involved in intestinal absorption |
| Q44684320 | In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection |
| Q38541574 | In vitro-in vivo correlations: general concepts, methodologies and regulatory applications |
| Q38131859 | In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications. |
| Q36403411 | Influence of simulated gastrointestinal conditions on particle-induced cytotoxicity and interleukin-8 regulation in differentiated and undifferentiated Caco-2 cells |
| Q38051672 | Inorganic matrices: an answer to low drug solubility problem |
| Q33541093 | Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties |
| Q43213690 | Ionogels as drug delivery system: one-step sol-gel synthesis using imidazolium ibuprofenate ionic liquid |
| Q50103796 | Lipids in the Stomach - Implications for the Evaluation of Food Effects on Oral Drug Absorption |
| Q35851242 | Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug. |
| Q41182158 | Liquisolid systems to improve the dissolution of furosemide |
| Q44110976 | Mathematical modeling of pH-surfactant-mediated solubilization of nimesulide |
| Q41016139 | Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways |
| Q33432960 | Mechanistic approaches to predicting oral drug absorption |
| Q64892391 | Micro-Injection Moulding of Poly(vinylpyrrolidone-vinyl acetate) Binary and Ternary Amorphous Solid Dispersions. |
| Q38182718 | Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility |
| Q37961539 | Models for oral uptake of nanoparticles in consumer products |
| Q82057920 | Multiple prototropism of fisetin in sodium cholate and related bile salt media |
| Q33548379 | Multivariate data analysis of factors affecting the in vitro dissolution rate and the apparent solubility for a model basic drug substance in aqueous media |
| Q39997486 | NPC1L1 and SR-BI are involved in intestinal cholesterol absorption from small-size lipid donors |
| Q34719056 | Nanomedicine in GI |
| Q33737183 | Nanonization of megestrol acetate by laser fragmentation in aqueous milieu |
| Q35069024 | Nanosizing: a formulation approach for poorly-water-soluble compounds |
| Q46814392 | Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation |
| Q57343790 | Nanotechnology as Emerging Tool for Enhancing Solubility of Poorly Water-Soluble Drugs |
| Q39100139 | New flurbiprofen derivatives: synthesis, membrane affinity and evaluation of in vitro effect on β-amyloid levels |
| Q42370595 | New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients |
| Q41871280 | Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. |
| Q51328469 | Novel piroxicam-loaded nanospheres generated by the electrospraying technique: physicochemical characterisation and oral bioavailability evaluation. |
| Q58119859 | On the Basicity of Conjugated Nitrogen Heterocycles in Different Media |
| Q46796981 | Optimization of self-microemulsifying drug delivery system for telmisartan using Box-Behnken design and desirability function |
| Q57086999 | Pharmaceutically Active Supported Ionic Liquids |
| Q44449451 | Physical stability of micronized powders produced by spray-freezing into liquid (SFL) to enhance the dissolution of an insoluble drug |
| Q37141404 | Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs |
| Q37538760 | Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition |
| Q36885247 | Prediction of human pharmacokinetics--gastrointestinal absorption |
| Q51564625 | Predictive models for drugs exhibiting negative food effects based on their biopharmaceutical characteristics. |
| Q45080292 | Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process. |
| Q54626013 | Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets. |
| Q33713176 | Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity |
| Q44305329 | Real-time dissolution behavior of furosemide in biorelevant media as determined by UV imaging |
| Q34733880 | Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery |
| Q36439180 | Recent progress in the computational prediction of aqueous solubility and absorption |
| Q36771350 | Release mechanisms for polyelectrolyte capsules |
| Q38383745 | Role of solvents in improvement of dissolution rate of drugs: crystal habit and crystal agglomeration |
| Q38383061 | Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems. |
| Q38199539 | Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead |
| Q56794329 | Simultaneous Determination of Assay and Related Substances in Nevirapine Suspension by HPLC |
| Q37932560 | Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs |
| Q41987417 | Solid-State Characterization and Interconversion of Recrystallized Amodiaquine Dihydrochloride in Aliphatic Monohydric Alcohols |
| Q44645197 | Solubilization of cyclosporin A in dextran-g-polyethyleneglycolalkyl ether polymeric micelles |
| Q30724402 | Solubilization of drugs by physiological mixtures of bile salts |
| Q44645352 | Solubilization of poorly water soluble drugs in micelles of hydrophobically modified hydroxypropylcellulose copolymers |
| Q90153555 | Structurally Characterized BODIPY-Appended Oxidovanadium(IV) β-Diketonates for Mitochondria-Targeted Photocytotoxicity |
| Q35892628 | Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery - dual uptake through enterocytes and M-cells. |
| Q37194117 | Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model. |
| Q36316895 | Supercritical fluid technology for enhanced drug delivery |
| Q36014479 | Superiority of liquid crystalline cubic nanocarriers as hormonal transdermal vehicle: comparative human skin permeation-supported evidence |
| Q92257789 | Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage |
| Q28082605 | Surface tension in human pathophysiology and its application as a medical diagnostic tool |
| Q41256954 | Surfactants modify the release from tablets made of hydrophobically modified poly (acrylic acid) |
| Q41987913 | The effect of acid pH modifiers on the release characteristics of weakly basic drug from hydrophlilic-lipophilic matrices. |
| Q44597484 | The effect of homogenization method on the properties of carbamazepine microparticles prepared by spray congealing |
| Q81399401 | The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids |
| Q37515447 | The pros and cons of polyelectrolyte capsules in drug delivery |
| Q39809409 | The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans |
| Q33954607 | The use of biorelevant dissolution media to forecast the in vivo performance of a drug |
| Q33683206 | Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles |
| Q90096583 | UniORV, a New Multi-Unit Dosage Form, Improved Biopharmaceutical Properties of Tacrolimus in Rats and Humans |
| Q46990357 | Use of simulated intestinal fluids with Caco-2 cells and rat ileum |
| Q83461108 | Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu |
| Q42646407 | Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug |
| Q46465572 | Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets |
| Q47959174 | pH-Sensitive Self-Assembled Microspheres Composed of Poly(Ethyleneimine) and Cinnamic Acid. |
| Q44272557 | pH-modulated release of insulin entrapped in a spontaneously formed hydrogel system composed of two water-soluble phospholipid polymers. |